Metropolis Healthcare Ltd
NSE:METROPOLIS

Watchlist Manager
Metropolis Healthcare Ltd Logo
Metropolis Healthcare Ltd
NSE:METROPOLIS
Watchlist
Price: 1 923.9 INR 0.2% Market Closed
Market Cap: 99.7B INR

Metropolis Healthcare Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Metropolis Healthcare Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Metropolis Healthcare Ltd
NSE:METROPOLIS
Operating Income
₹2.1B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Dr Agarwal's Eye Hospital Ltd
BSE:526783
Operating Income
₹923.1m
CAGR 3-Years
23%
CAGR 5-Years
119%
CAGR 10-Years
33%
Thyrocare Technologies Ltd
NSE:THYROCARE
Operating Income
₹1.7B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Operating Income
₹5.9B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
16%
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
Operating Income
₹2B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Krsnaa Diagnostics Ltd
NSE:KRSNAA
Operating Income
₹1B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Metropolis Healthcare Ltd
Glance View

Market Cap
99.7B INR
Industry
Health Care

Metropolis Healthcare Ltd., a pioneer in the diagnostics industry, embarked on its journey in 1980 under the visionary leadership of Dr. Sushil Kanubhai Shah. This Mumbai-based company quickly established itself as a trusted name, offering a comprehensive range of diagnostic services, including pathology tests, radiology, and wellness solutions. The heart of its operations lies in its expansive network of laboratories and collection centers strategically distributed across India and several international locations. By leveraging state-of-the-art technology and maintaining rigorous quality standards, Metropolis has positioned itself as a forerunner in providing precise and reliable medical test results. This was especially crucial as the demand for accurate healthcare diagnostics surged, driven by an increasingly health-conscious population. Metropolis generates its revenue primarily through fees charged for its broad spectrum of diagnostic tests that cater to a variety of health needs, from routine screenings to specialized, high-complexity tests. Its business model capitalizes on partnerships with healthcare providers, hospitals, and corporations, offering customized health packages and diagnostic solutions that ensure a steady flow of clientele. By integrating advanced testing technologies and continuously expanding its service portfolio, the company taps into diverse revenue streams, which include corporate wellness programs and home health services. This diversified approach not only enhances its financial stability but also solidifies its reputation as a go-to healthcare partner for individuals, corporate clients, and healthcare institutions alike.

METROPOLIS Intrinsic Value
1 663.13 INR
Overvaluation 14%
Intrinsic Value
Price

See Also

What is Metropolis Healthcare Ltd's Operating Income?
Operating Income
2.1B INR

Based on the financial report for Sep 30, 2025, Metropolis Healthcare Ltd's Operating Income amounts to 2.1B INR.

What is Metropolis Healthcare Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
4%

Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for Metropolis Healthcare Ltd have been -1% over the past three years , 4% over the past five years .

Back to Top